Clinical Trials Browser

Phase 1/2 × Leukemia × Immunotherapy, Adoptive × Clear all

NCT07020260 2025-06-13

PACMAN

Phase 1/2 Not yet recruiting

LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Leukemia, Lymphoma